Prostate cancer: combination of vaccine plus ipilimumab--safety and toxicity

Nat Rev Urol. 2012 May 8;9(6):302-3. doi: 10.1038/nrurol.2012.103.
No abstract available

Publication types

  • News

MeSH terms

  • Antibodies, Monoclonal / administration & dosage*
  • Antibodies, Monoclonal / adverse effects
  • CTLA-4 Antigen / antagonists & inhibitors
  • CTLA-4 Antigen / immunology
  • Cancer Vaccines / administration & dosage*
  • Cancer Vaccines / adverse effects
  • Drug Therapy, Combination
  • Humans
  • Ipilimumab
  • Male
  • Prostatic Neoplasms / drug therapy*
  • Prostatic Neoplasms / immunology

Substances

  • Antibodies, Monoclonal
  • CTLA-4 Antigen
  • Cancer Vaccines
  • Ipilimumab